sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> antibody production market

report

Antibody Production Market, by Products (Single-use Bioreactors, Reagents, Buffers, Media, Chromatography Instruments, Resins, Filtration Systems, Consumables, Accessories), Applications (Monoclonal, Polyclonal) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC188 November 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the antibody production market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the antibody production market. The scope of this report covers the antibody production market by its major segments, which include the products, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Meticulous understanding of the key new market opportunities in individual geographic regions/countries
  • Detailed analysis of the significant sustainability strategies adopted by the major players in this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Patent expiration of blockbuster antibodies, increasing adaptation of targeted antibodies, increase in research and development by pharmaceutical and biotechnology companies, and the improved approval rate of the therapeutic antibodies are the major drivers of the antibody production market.
  • The increasing prevalence of infectious diseases and growing demand for protein therapy are the future opportunities for the pharmaceutical giants in this market.
  • However, the low number of financially accessible immune response drug conjugates combined with high cost, prompts decrease in their uptake and restrains the growth of the antibody production market.
  • Moreover, the high cost associated with antibody production and strict government regulations may hamper the market growth.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s antibody production market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the antibody production market by the following segments:

  • Antibody Production Market, by Products
    • Single-use Bioreactors
    • Large-scale Bioreactors
    • Reagents and Buffers
    • Media
    • Chromatography Instruments
    • Chromatography Resins
    • Filtration Systems
    • Filtration Consumables and Accessories
  • Antibody Production Market, by Applications
    • Monoclonal Antibodies
    • Polyclonal Antibodies

KEY MARKET PLAYERS

Key players in the antibody production market include:

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Roche Diagnostics
  • GE Healthcare
  • Abcam plc.
  • Eli Lilly and Company
  • Sigma-Aldrich Co.
  • Genentech, Inc.
  • GeneTex Inc.
  • Merck KGaA

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Antibody Production Market

TRENDING RELATED REPORT

Synthetic Biology Market, by Product (Core Products and Enabling Products), Application (Chemical, Healthcare and Agriculture), Technology (Genome Engineering, DNA Sequencing, Bioinformatics and Biological Components and Integration Systems) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Issues
    3. Ecosystem Analysis
  5. ANTIBODY PRODUCTION MARKET, BY PRODUCTS
    1. Segment Share
    2. By Products
      1. Single-use Bioreactors
      2. Large-scale Bioreactors
      3. Reagents and Buffers
      4. Media
      5. Chromatography Instruments
      6. Chromatography Resins
      7. Filtration Systems
      8. Filtration Consumables and Accessories
  6. ANTIBODY PRODUCTION MARKET, BY APPLICATIONS
    1. Segment Share
    2. By Applications
      1. Monoclonal Antibodies
      2. Polyclonal Antibodies
  7. ANTIBODY PRODUCTION MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Products
      3. By Applications
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Products
      3. By Applications
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Products
      3. By Applications
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Products
      3. By Applications
  8. COMPETITIVE LANDSCAPE
  9. KEY MARKET PLAYERS
    1. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    2. Thermo Fisher Scientific, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    3. Roche Diagnostics
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    4. GE Healthcare
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    5. Abcam plc.
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    6. Eli Lilly and Company.
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    7. Sigma-Aldrich Co. 
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    8. Genentech, Inc. 
      1. Overview
      2. Key Strategies
      3. Recent Developments.
    9. GeneTex Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Merck KGaA
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10.  SCALAR 360 DEGREE MARKET PERSPECTIVE
  11.  APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us